CompoAtlas

VEINIPHYM

Food supplement declared in France, declaration No 2020-1-863

VEINIPHYM (LABORATOIRES IPHYM) is a food supplement declared in France. Status: retrait du marché annoncé pour le 4 July 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
LABORATOIRES IPHYM
Food business operator placing the product on the market
Laboratoires IPHYM
Status
Retrait du marché annoncé pour le 4 July 2027
Form
Gélule
Daily dose
3 gélules par jour
Directions for use
Prendre 3 gélules par jour.
Not recommended for (according to the manufacturer)
Femmes enceintes, Sous anticoagulants

Declaration 216528, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Aesculus hippocastanum L.GraineExtrait sec hydroalcoolique375 mg
Ruscus aculeatus L.RhizomeExtrait sec hydroalcoolique375 mg

Additives

E470b, E551

Other ingredients

Gélule végétale

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux femmes enceintes et aux personnes sous anticoagulant. Ne pas dépasser la dose journalière recommandée. Ne se substitue pas à un régime alimentaire varié et sera utilisé dans le cadre d'un mode de vie sain. Ne pas laisser à la portée des jeunes enfants.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : LABORATOIRES IPHYM

Enter to analyse, Shift+Enter for a new line